FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

Finding New Roles for Top Talent

Jan. 15, 2016 - The true power of organizations lies in their people. This is especially true of SWOG, a nearly all-volunteer organization, whose strength comes from the hundreds of members who give us thousands of hours of effort every year. We have some of the country's best minds in cancer research and, indeed, medicine itself, in our ranks – and I want to take full advantage!

That's why I am telling you about a new role here at SWOG, for two members who are near and dear to my heart.

Drs. David Gandara and Frank Meyskens both just stepped down from top leadership roles, Dr. Gandara as lung committee chair and Dr. Meyskens as vice chair of our National Community Oncology Research Program. Now, I am pleased to report, they each take on a new SWOG position: senior advisor.

Senior advisors will do just that -- advise me and members of the group chair's office on the best path forward on thorny or important issues, as well as leading in areas critical to SWOG's mission and principles.

They also have some unique duties. As one of our most productive, exacting, and longest-standing committee chairs, Dr. Gandara will co-direct, with Dr. Cathy Eng, our new leadership development course for young investigators that is currently in development. As we tighten policy and improve efficiency, Dr. Gandara will also help clarify and define the roles of SWOG committee chairs and executive officers.

As a national expert in cancer prevention, with a distinguished 40-year career, and one of SWOG's most committed and progressive leaders, Dr. Meyskens will serve as SWOG's liaison to the National Cancer Institute for our cancer prevention efforts, provide leadership on patient recruitment and retention, and explore the creation of an end of life research program at SWOG.

This new senior advisor role should be put into context. There is a vital need for it. For two years, we've been enforcing new term limits for our committee chairs. Yet, at the same time, the opportunities and challenges we face have never been greater. With limitless possibilities in precision medicine -- but with a limited supply of money, time, and talent to pursue them -- we need to make the most of our most precious resource -- our people. In a similar vein, knowing committee chair and other leadership roles are not as plentiful as we would like, we will explore creating other positions to keep our young investigators engaged with SWOG.

So stay tuned for more new roles, including ones that make good use of our patient advocates. We will continue to cultivate our future leaders, and make every effort to use the skills and knowledge of our past ones.